Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Genpact (G) Shares Outstanding (Diluted Average) (2019 - 2026)

Genpact has reported Shares Outstanding (Diluted Average) over the past 10 years, most recently at $176.6 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 2.1% year-over-year to $176.6 million; the TTM value through Dec 2025 reached $176.6 million, down 2.1%, while the annual FY2025 figure was $176.6 million, 2.1% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $176.6 million at Genpact, roughly flat from $176.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $193.2 million in Q1 2021 and troughed at $176.1 million in Q3 2025.
  • A 5-year average of $185.1 million and a median of $186.2 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): fell 0.62% in 2023 and later fell 3.01% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $193.0 million in 2021, then fell by 2.53% to $188.1 million in 2022, then decreased by 1.57% to $185.1 million in 2023, then dropped by 2.54% to $180.4 million in 2024, then decreased by 2.1% to $176.6 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for G at $176.6 million in Q4 2025, $176.1 million in Q3 2025, and $177.1 million in Q2 2025.